REFERENCES
- Evoli A, Batocchi AP, Minisci C, Di Schino C, Tonali P. Therapeutic options in ocular myasthenia gravis. Neuromusc Dis. 2001; 11: 208–216
- Victor M, Ropper AH. Myasthenia gravis and related disorders of the neuromuscular junction. Adams and Victor's Principles of Neurology, M Victor, AH Ropper, McGraw-Hill 2001; 1536–1547
- Sommer N, Sigg B, Melms A, et al. Ocular myasthenia gravis: Response to long-term immunosuppressive treatment. J Neurol Neurosurg Psychiatry 1997; 62: 156–162
- Keesey J. A treatment algorithm for autoimmune myasthenia in adults. Ann N Y Acad Sci. 1998; 841: 753–768
- Arsura EL, Bick A, Brunner NG, Namba T, Grob D. High-dose intravenous immunoglobulin in the management of myasthenia gravis. Arch Intern Med. 1986; 146: 1365–1368
- Cosi V, Lombardi M, Piccolo G, Erbetta A. Treatment of myasthenia gravis with high-dose immunoglobulin. Acta Neurol Scand. 1991; 84: 81–84
- Fateh-Moghadam A, Wick M, Besinger U, Geursen RG. High-dose intravenous gammaglobulin for myasthenia gravis. Lancet 1984; 1: 848–849
- Gajdos P, Chevret S, Clair B, Tranchant C, Chastang C. Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Ann Neurol. 1997; 41: 789–796
- Gajdos P, Outin H, Elkharrat D, et al. High-dose intravenous gammaglobulin for myasthenia gravis. Lancet 1984; 1: 406–407
- Hilkevich O, Drory VE, Chapman J, Korczyn A. The use of intravenous immunoglobulin as maintenance therapy in myasthenia gravis. Clin Neuropharmacol. 2001; 24: 173–176
- Horton RH, Manfredi AA, Conti-Tronconi BM. The “embryonic” γ subunit of the nicotinic acetylcholine receptor is expressed in adult extrinsic ocular muscles. Neurology 1993; 43: 983–986
- Wang ZY, Okita DK, Howard J, Conta-Fine M. T-cell recognition of muscle acetylcholine receptor subunits in generalized and ocular myasthenia gravis. Neurology 1998; 50: 1045–1054
- Kaminski HJ, Richmonds CR, Kusner LL, Mitsumoto H. Differential susceptibility of the ocular motor system to disease. Ann N Y Acad Sci. 2002; 956: 42–54
- Yu Wai, Man CY, Chinnery PF, Griffiths PG. Extraocular muscles have fundamentally distinct properties that make them selectively vulnerable to certain disorders. Neuromuscul Disord. 2005; 15: 17–23